• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.13% Nasdaq Up 0.14%

    NovaBay Pharmaceuticals, Inc. (NBY)

    -NYSE MKT
    2.34 Down 0.01(0.32%) Jul 29, 3:59PM EDT
    Prev Close:2.34
    Open:2.28
    Bid:2.31 x 100
    Ask:2.34 x 200
    1y Target Est:27.12
    Beta:-0.784063
    Earnings Date:Aug 11 - Aug 15 (Est.)
    Day's Range:2.28 - 2.34
    52wk Range:1.75 - 15.00
    Volume:15,891
    Avg Vol (3m):42,110
    Market Cap:21.40M
    P/E (ttm):N/A
    EPS (ttm):-5.95
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBY

    Comparison

    Symbol% ChgMkt Cap
    NBYDown 0.32%21.40M
    ABTUp 0.67%65.74B
    SNNUp 1.96%14.88B
    PFEUp 0.60%223.73B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.86
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-2.03
    Quarterly EPS Est (Jun-16) :-0.30
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes non-antibiotic anti-infective products for the eye care market in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback